| Literature DB >> 35547988 |
Sha-Sha Ge1, Biao Chen1, Yuan-Yuan Wu1, Qing-Su Long1, Yong-Liang Zhao1, Pei-Yi Wang1, Song Yang1,2.
Abstract
Photoaffinity labeling (PAL) in combination with a chemical probe to covalently bind its target upon UV irradiation has demonstrated considerable promise in drug discovery for identifying new drug targets and binding sites. In particular, carbene-mediated photoaffinity labeling (cmPAL) has been widely used in drug target identification owing to its excellent photolabeling efficiency, minimal steric interference and longer excitation wavelength. Specifically, diazirines, which are among the precursors of carbenes and have higher carbene yields and greater chemical stability than diazo compounds, have proved to be valuable photolabile reagents in a diverse range of biological systems. This review highlights current advances of cmPAL in medicinal chemistry, with a focus on structures and applications for identifying small molecule-protein and macromolecule-protein interactions and ligand-gated ion channels, coupled with advances in the discovery of targets and inhibitors using carbene precursor-based biological probes developed in recent decades. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35547988 PMCID: PMC9084484 DOI: 10.1039/c8ra03538e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Proposed mechanisms of different types of photoaffinity labeling: (A) azide (AZ), (B) benzophenone (BP), (C) diazirine (DZ), (D) 2-aryl-5-carboxytetrazole (ACT), and two “more natural” types, namely, (E) pyrimidone, and (F) pyrone. X = C, N, O, or S.
Fig. 2Structure of carbenes derived from diazo compounds or diazirines upon UV irradiation.
Fig. 3Photochemical reaction of diazoketone 1 for photoaffinity labeling, including an insertion reaction and a Wolff rearrangement.
Scheme 1Photochemical reaction of ethyl diazotrifluoropropanoate.
Fig. 4Typical methods for preparing diazo compounds: (a) diazo transfer; (b) diazotization; (c) decomposition or oxidation of hydrazones; (d) rearrangement of N-alkyl-N-nitroso compounds; (e) fragmentation of 1,3-disubstituted alkyl aryl triazenes; and (f) elaboration of more readily available diazo compounds.
Fig. 5Possible pathways and intermediates formed after photolysis of 3-aryl-3H-diazirines and representation of the electronic states of the carbene.
Scheme 2Synthetic routes to the aromatic diazirine 10 from the aromatic bromide 2 or the aromatic formaldehyde 3.
Summary of steps in the synthesis of aromatic diazirines. MsCl: mesyl chloride; Py: pyridine; pTsCl: p-tosyl chloride; DMAP: N,N-dimethyl-4-aminopyridine
| Step | Synthetic conditions | Ref. |
|---|---|---|
| A1 |
|
|
|
|
| |
| Mg, CF3COR, R = piperidinyl |
| |
| Mg/CF3COOH or |
| |
| A2 | (1) TMS-CF3, catalytic TBAF, THF; then aqueous HCl |
|
| (2) Dess-Martin periodinane, TFA, CH2Cl2 | ||
| (1) TMS-CF3, K2CO3, DMA, rt, 2 h |
| |
| (2) 1 M HCl, rt, 1 h | ||
| (3) Dess-Martin, CH2Cl2, rt, 8 h | ||
| B1 | NH2OH, NaOH, EtOH, reflux, 21 h |
|
| NH2OH·HCl, pyridine, EtOH, 60 °C, 4 h |
| |
| NH2OH·HCl, NaOH, EtOH, reflux, 16 h or pyridine, 70 °C, 3 h |
| |
| B2 | 1 M LiN(TMS)2 in THF, toluene, 0 °C |
|
| C | MsCl, TEA |
|
| TsCl, pyridine, reflux |
| |
| TsCl, TEA, |
| |
| TsCl, DMAP, TEA, CH2Cl2, rt, 45 min |
| |
| D1 | NH3 (l), CH2Cl2, −78 °C |
|
| NH3 (l), ether, −78 °C→rt or rt |
| |
| NH3 (l), 80 °C, 20 h |
| |
| D2 | NH3 (l), LiNH2, rt, 11 h |
|
| M | MeOH, 18 h |
|
| N | (1) |
|
| (2) piperidine | ||
| E | Ag2O, ether, 23 °C, 3.5 h |
|
| tert-BuOCl, TEA |
| |
| I2, TEA, CH2Cl2 or MeOH, 0 °C |
| |
| MnO2, ether or CH2Cl2, rt |
| |
| (COCl)2, DMSO, DCM, −78 °C |
|
Scheme 3Schematic of the syntheses of the minimalist alkyne linkers L1–3: HOSA: hydroxylamine-O-sulfonic acid; [O]: Ag2O, I2/TEA or CrO3; DIBAL: diisobutylaluminium hydride.
Fig. 6Diazirine analogues of amino acids.
Fig. 7Structures of diazirinyl nucleic acid analogues and the 5-iodouridine RNA derivative 28.
Fig. 8Diazirine analogues of lipids.
Fig. 9Diazirine analogues of carbohydrates.
Fig. 10Diazirine analogues of steroids.
Fig. 11Structures of propofol and its diazirinyl analogues.
Fig. 12Etomidate and its diazirinyl analogues.
Fig. 13Representative applications of cmPAL for studying kinases.
Fig. 14Representative applications of cmPAL for studying γ-secretase.
Fig. 15Representative applications of cmPAL for studying methyltransferases.
Fig. 16Representative applications of cmPAL for studying metalloproteases.
Fig. 17Representative applications of cmPAL for studying histone deacetylases.
Fig. 18Representative applications of cmPAL for studying DNA polymerase.
Fig. 19Representative applications of cmPAL for studying ATPases.
Fig. 20Representative applications of cmPAL for studying protein tyrosine phosphatase 1B.
Fig. 21Representative applications of cmPAL for studying methionine aminopeptidase.
Fig. 22Structures of 4′-demethyl-4b-podophyllotoxin derivatives.
Fig. 23Representative applications of cmPAL for studying sialidases.
Fig. 24Structures of photoreactive acidic α-amino acid analogues.